GlassScriptPhysician profile
Edward Herrman
NPI 1518950187
$5,817.23
in general payments reported to CMS, 2019-2025
39 companies · $1,497 in 2025
The $1,497 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,058 · 2020: $395 · 2021: $359 · 2022: $892 · 2023: $888 · 2024: $729 · 2025: $1,497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,021 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $92.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,021.23 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $92.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $929.74 | 2019-2025 | Xtandi, Myrbetriq |
| Karl Storz Endoscopy-America | $653.87 | 2019-2022 | |
| Axonics, INC. | $440.69 | 2022-2024 | Axonics |
| Bluewind Medical | $329.46 | 2025 | |
| Dornier Medtech America, INC | $308.67 | 2025 | Dornier Medtech |
| Endo Pharmaceuticals INC. | $303.20 | 2019-2024 | Aveed, Edex, Xiaflex |
| Sumitomo Pharma America, INC. | $284.36 | 2023-2025 | Gemtesa, Orgovyx |
| Endo USA, INC. | $203.15 | 2024-2025 | Aveed, Xiaflex, Edex |
| Boston Scientific Corporation | $167.91 | 2019-2025 | Spaceoar Vue System - 10ml, Lumenis Pulse 120h |
| Bayer Healthcare Pharmaceuticals INC. | $167.56 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $152.68 | 2022-2025 | |
| Ferring Pharmaceuticals INC. | $149.90 | 2019-2025 | Adstiladrin |
| Coloplast Corp | $148.53 | 2019-2025 | |
| Biocompatibles, INC. | $148.24 | 2019 | |
| Procept Biorobotics Corporation | $137.31 | 2022-2025 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $134.77 | 2019-2025 | Erleada |
| Abbvie INC. | $118.35 | 2022-2025 | |
| Blue Earth Diagnostics | $109.91 | 2019-2024 | |
| C. R. Bard, INC. & Subsidiaries | $102.48 | 2023 | Bard Urinary Drainage Bag |
| 180 Medical, INC. | $92.62 | 2019-2020 | |
| Rochester Medical Corporation | $86.91 | 2022 | |
| Urovant Sciences INC | $81.44 | 2021-2022 | |
| Pfizer INC. | $76.93 | 2020-2025 | |
| Laborie Medical Technologies Corp. | $75.65 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Olympus America INC. | $71.10 | 2022-2024 | Itind System |
| Verity Pharmaceuticals INC. | $55.64 | 2022-2024 | Trelstar |
| Teleflex LLC | $44.37 | 2022-2024 | Urolift |
| Medtronic, INC. | $31.45 | 2021-2023 | Interstim |
| Tolmar, INC. | $25.17 | 2025 | Eligard |
| Merck Sharp & Dohme LLC | $25.10 | 2025 | Keytruda |
| Accord Healthcare, INC. | $24.19 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $20.75 | 2024 | Lynparza |
| Urogen Pharma, INC. | $17.47 | 2024 | |
| Calyxo, INC. | $17.24 | 2025 | Cvac Aspiration System |
| Medtronic USA, INC. | $17.03 | 2019 | |
| Antares Pharma, INC. | $16.68 | 2022 | |
| Myovant Sciences INC. | $16.02 | 2022 | |
| Neotract INC. | $15.74 | 2019 | |
| Bioprotect Medical, INC. | $14.95 | 2024 | Bioprotect Balloon Implant System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Herrman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.